FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

ADAPYAdaptimmune Therapeutics PLC

Inspect →

ADBEADOBE INC.

Inspect →

ADBTAdvasa Holdings, Inc.

Inspect →

ADCAGREE REALTY CORP

Inspect →

ADCTADC Therapeutics SA

Inspect →

ADDTFAddtech AB/ADR

Inspect →

ADEAAdeia Inc.

Inspect →

ADGMAdagio Medical Holdings, Inc.

Inspect →

ADIANALOG DEVICES INC

Inspect →

ADIAAdia Med, Inc.

Inspect →

ADIGADI GLOBAL DISTRIBUTION INC.

Inspect →

ADILADIAL PHARMACEUTICALS, INC.

Inspect →

03 / FINANCIAL CHANGES

Stoke Therapeutics, Inc. STOK

Pharmaceutical Preparations · SIC 2834

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-03 · Retrieved: 2026-11-04

Compared with the same period of the prior year, ending 2025-09-30.

Revenue11.26

USD million

Change year over year: +0.62 · +5.9%

Net income-73.64

USD million

Change year over year: -35.30

Operating cash flow-62.69

USD million

Change year over year: -32.32

Total liabilities54.10

USD million

Change year over year: +1.95

Total assets406.69

USD million

Change year over year: +46.43

Liabilities / assets: 13.3% · Change: -1.2 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-03-16 · Retrieved: 2026-11-04

Compared with the same period of the prior year, ending 2024-12-31.

Revenue184.42

USD million

Change year over year: +147.87 · +404.5%

Net income-6.89

USD million

Change year over year: +82.10

Operating cash flow45.59

USD million

Change year over year: +132.44

Total liabilities65.98

USD million

Change year over year: +23.44

Total assets418.43

USD million

Change year over year: +146.88

Liabilities / assets: 15.8% · Change: +0.1 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
MRK ↗	2025-12-31	65,011.00	28.1%	25.3%
NATR ↗	2025-12-31	480.14	4.1%	7.4%
TENX ↗	2025-12-31	0.00	—	—
RAPP ↗	2025-12-31	—	—	—
NTHI ↗	2025-12-31	0.04	-155,404.4%	-50,922.6%
ZBIO ↗	2025-12-31	10.00	-3,777.4%	-1,723.3%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

CAH ↗

CARDINAL HEALTH INC

Filed: 2026-11-05
Period ending: 2026-09-30

Latest standalone quarter

APYX ↗

Apyx Medical Corp

Filed: 2026-11-05
Period ending: 2026-09-30

Latest standalone quarter

FUSB ↗

FIRST US BANCSHARES, INC.

Filed: 2026-11-05
Period ending: 2026-09-30

Latest standalone quarter

RGS ↗

REGIS CORP

Filed: 2026-11-05
Period ending: 2026-09-30

Latest standalone quarter

GHM ↗

GRAHAM CORP

Filed: 2026-11-05
Period ending: 2026-09-30

Latest standalone quarter

ACNB ↗

ACNB CORP

Filed: 2026-11-05
Period ending: 2026-09-30

Latest standalone quarter

PAR ↗

PAR TECHNOLOGY CORP

Filed: 2026-11-05
Period ending: 2026-09-30

Latest standalone quarter

DSGR ↗

Distribution Solutions Group, Inc.

Filed: 2026-11-05
Period ending: 2026-09-30

Latest standalone quarter

AJG ↗

Arthur J. Gallagher & Co.

Filed: 2026-11-05
Period ending: 2026-09-30

Latest standalone quarter

BUSE ↗

FIRST BUSEY CORP /NV/

Filed: 2026-11-05
Period ending: 2026-09-30

Latest standalone quarter

HAE ↗

HAEMONETICS CORP

Filed: 2026-11-05
Period ending: 2026-09-26

Latest standalone quarter

ZION ↗

ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/

Filed: 2026-11-05
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →